Related topics: cancer , breast cancer , tumor
Transforming growth factor
hideTransforming growth factor (sometimes referred to as Tumor growth factor, or TGF) is used to describe two classes of polypeptide growth factors, TGFα and TGFβ.
The name "Transforming Growth Factor" is somewhat arbitrary, since the two classes of TGFs are not structurally or genetically related to one another, and they act through different receptor mechanisms. Furthermore, they do not always induce cellular transformation, and are not the only growth factors that induce cellular transformation.
For more information about Transforming growth factor, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with tumor growth
Scientists engineer new type of vaccination that provides instant immunity
Mar 02, 2009 |
4.6 / 5 (19) |
0
The experiments, thus far performed only in mice, appear to overcome a major drawback of vaccinations - the lag time of days, or even weeks, that it normally takes for immunity to build against a pathogen. This new method ...
Study shows immune system can hurt as well as help fight cancer
Sep 29, 2008 |
4.7 / 5 (7) |
0
Researchers at the University of Pennsylvania School of Medicine have found that some proteins of the immune system can promote tumor growth. Investigators found that instead of fighting tumors, the protein ...
Grapefruit juice boosts drug's anti-cancer effects
Apr 20, 2009 |
4.6 / 5 (7) |
1
In a small, early clinical trial, researchers at the University of Chicago Medical Center have found that combining eight ounces of grapefruit juice with the drug rapamycin can increase drug levels, allowing lower doses of ...
Nanoparticles for gene therapy improve
Nanotechnology / Bio & Medicine
Nov 06, 2009 |
5 / 5 (5) |
3
(PhysOrg.com) -- About five years ago, Professor Janet Sawicki at the Lankenau Institute in Pennsylvania read an article about nanoparticles developed by MIT's Robert Langer for gene therapy, the insertion ...
Trojan horse for ovarian cancer -- nanoparticles turn immune system soldiers against tumor cells
Nanotechnology / Bio & Medicine
Jul 15, 2009 |
5 / 5 (5) |
1
In a feat of trickery, Dartmouth Medical School immunologists have devised a Trojan horse to help overcome ovarian cancer, unleashing a surprise killer in the surroundings of a hard-to-treat tumor.
Researchers develop novel anti-tumor vaccine
Oct 02, 2008 |
4.8 / 5 (5) |
0
A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact ...
SIRT1 takes down tumors
Apr 13, 2009 |
4.6 / 5 (5) |
0
Yuan et al. have identified another anti-cancer effect of the "longevity" protein SIRT1. By speeding the destruction of the tumor promoter c-Myc, SIRT1 curbs cell division. The study will be published online ...
'Self-seeding' of cancer cells may play a critical role in tumor progression
Dec 24, 2009 |
5 / 5 (4) |
0
Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers ...
Stress May Hasten The Growth Of Melanoma Tumors But Common Beta-Blocker Medications Might Slow That Progress
Jan 30, 2009 |
5 / 5 (4) |
0
For patients with a particularly aggressive form of skin cancer - malignant melanoma - stress, including that which comes from simply hearing that diagnosis, might amplify the progression of their disease.
Researchers 'notch' a victory toward new kind of cancer drug
Nov 11, 2009 |
4 / 5 (4) |
1
(PhysOrg.com) -- Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery, published in ...
Protein is linked to lung cancer development
Oct 22, 2009 |
5 / 5 (3) |
0
(PhysOrg.com) -- A protein that normally helps defend cells from infection can play a critical role in the development of lung cancer, according to MIT cancer biologists.
Diabetes drug kills cancer stem cells in combination treatment in mice
Sep 14, 2009 |
5 / 5 (3) |
0
In a one-two punch, a familiar diabetes drug reduced tumors faster and prolonged remission in mice longer than chemotherapy alone by targeting cancer stem cells, Harvard Medical School researchers reported in the September ...
Researchers identify potential target for metastatic cancer
Aug 10, 2009 |
5 / 5 (3) |
0
The deadliest part of the cancer process, metastasis, appears to rely on help from macrophages, potent immune system cells that usually defend vigorously against disease, researchers at Albert Einstein College ...
Nanoparticle-delivered 'suicide' genes slowed ovarian tumor growth (w/ Video)
Jul 30, 2009 |
5 / 5 (3) |
0
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to ...
Knockdown of E2F1 reduces invasive potential of melanoma cells
Dec 23, 2009 |
4 / 5 (2) |
0
Inhibition of transcription factor E2F1 reduced epidermal growth factor receptor (EGFR) expression and reduced the invasive potential but not proliferation of metastatic melanoma cells, according to a brief communication ...
